Follow
Vedang Murthy
Vedang Murthy
Tata Memorial Centre
Verified email at actrec.gov.in
Title
Cited by
Cited by
Year
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
5202018
Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT
E Vanetti, A Clivio, G Nicolini, A Fogliata, S Ghosh-Laskar, JP Agarwal, ...
Radiotherapy and Oncology 92 (1), 111-117, 2009
4312009
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
T Gupta, Z Master, S Kannan, JP Agarwal, S Ghsoh-Laskar, V Rangarajan, ...
European journal of nuclear medicine and molecular imaging 38, 2083-2095, 2011
3992011
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
3632020
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial
T Gupta, JP Agarwal, S Jain, R Phurailatpam, S Kannan, S Ghosh-Laskar, ...
Radiotherapy and Oncology 104 (3), 343-348, 2012
3602012
Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial
V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ...
Journal of Clinical Oncology 36 (11), 1064-1072, 2018
3142018
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
2912014
Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial
V Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ...
Journal of Clinical Oncology 39 (11), 1234-1242, 2021
2232021
Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ...
European urology 76 (6), 831-842, 2019
2132019
Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three …
S Rathod, T Gupta, S Ghosh-Laskar, V Murthy, A Budrukkar, JP Agarwal
Oral oncology 49 (6), 634-642, 2013
1622013
Hypofractionated, palliative radiotherapy for advanced head and neck cancer
JP Agarwal, B Nemade, V Murthy, S Ghosh-Laskar, A Budrukkar, T Gupta, ...
Radiotherapy and Oncology 89 (1), 51-56, 2008
1332008
Prospective randomized controlled trial to compare 3‐dimensional conformal radiotherapy to intensity‐modulated radiotherapy in head and neck squamous cell carcinoma: Long‐term …
S Ghosh–Laskar, PH Yathiraj, D Dutta, V Rangarajan, N Purandare, ...
Head & neck 38 (S1), E1481-E1487, 2016
1202016
Introduction of situation, background, assessment, recommendation into nursing practice: a prospective study
MS Achrekar, V Murthy, S Kanan, R Shetty, M Nair, N Khattry
Asia-Pacific journal of oncology nursing 3 (1), 45-50, 2016
1192016
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ...
Cancer 125 (18), 3184-3197, 2019
1062019
A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer
R Venkitaraman, D Lorente, V Murthy, K Thomas, L Parker, R Ahiabor, ...
European urology 67 (4), 673-679, 2015
1032015
Objective assessment of swallowing function after definitive concurrent (chemo) radiotherapy in patients with head and neck cancer
J Agarwal, V Palwe, D Dutta, T Gupta, SG Laskar, A Budrukkar, V Murthy, ...
Dysphagia 26, 399-406, 2011
992011
‘Plan of the day’adaptive radiotherapy for bladder cancer using helical tomotherapy
V Murthy, Z Master, P Adurkar, I Mallick, U Mahantshetty, G Bakshi, ...
Radiotherapy and Oncology 99 (1), 55-60, 2011
882011
Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy
V Murthy, JP Agarwal, SG Laskar, T Gupta, A Budrukkar, P Pai, ...
Journal of cancer research and therapeutics 6 (3), 282-289, 2010
872010
Mucoepidermoid carcinoma of the parotid gland: factors affecting outcome
S Ghosh‐Laskar, V Murthy, T Wadasadawala, J Agarwal, A Budrukkar, ...
Head & neck 33 (4), 497-503, 2011
812011
Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021
S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, ...
European urology 82 (1), 115-141, 2022
692022
The system can't perform the operation now. Try again later.
Articles 1–20